COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX®

12/06/2017 - 08:00

Press Release 12 June 2017 Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX® --New Designation is One of the First Cell-based Therapy Names Established by the [...]

Basilea announces clinical study agreement with Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma

12/06/2017 - 07:15

The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for malignant brain tumors. It is funded by the US National Cancer Institute (NCI). The ABTC will conduct a clinical phase 1 study [...]

TiGenix announces final equity payment for cardiac platform acquisition

12/06/2017 - 07:00

PRESS R ELEASE regulated information Leuven (BELGIUM) - June 12, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory [...]

TiGenix annonce le paiement final en actions pour l'acquisition de sa plateforme cardiaque

12/06/2017 - 07:00

Communiqué de Presse Information réglementée Louvain (BELGIQUE) - 12 juin 2017, 7:00 h CEST - TiGenix NV (Euronext Brussels et NASDAQ: TIG), une société biopharmaceutique de pointe spécialisée dans l'exploration de [...]

Probiodrug announces encouraging results of the Phase 2a SAPHIR Study

11/06/2017 - 21:06

Probiodrug announces encouraging results of the Phase 2a SAPHIR Study HALLE (SAALE), Germany, 11 June 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to [...]

Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia

11/06/2017 - 17:01

Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent ® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia - Data presented at the 77 th Scientific Sessions of [...]

Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie

11/06/2017 - 17:01

Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent ® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie - Les données de ces [...]

New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%

10/06/2017 - 19:14

Pressrelease - No. 6/2017 New analysis shows Soliqua ® 100/33 lowered HbA 1c by more than 2% in patients with screening levels greater than 9% All subgroups treated with Soliqua ® 100/33 achieved a mean HbA 1c of less [...]

Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia

10/06/2017 - 19:08

Press Release - No. 5/2017 Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia Elaborated results from Phase 2 [...]

XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis

09/06/2017 - 21:10

AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that an Independent Data Monitoring Committee (IDMC) has performed its second prospectively planned, unblinded analysis of the [...]

Medable Launches Synapse, a Fully Integrated Clinical Care App Platform Using CareKit

09/06/2017 - 19:10

Medable's next generation disease management solution seeks to significantly improve health outcomes through provider and patient directed apps that track and trend patient health in real-time PALO ALTO, Calif., June 09 [...]

Medable lance Synapse, une plateforme d'application de soins cliniques intégralement intégrée utilisant CareKit

09/06/2017 - 19:10

La solution de gestion des maladies de la prochaine génération de Medable vise à améliorer significativement les résultats en matière de santé grâce à des applications destinées aux prestataires de soins et aux patients [...]

Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange

09/06/2017 - 17:45

ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Actelion Ltd (SIX:ATLN) today published the listing prospectus relating to the listing of Idorsia shares on SIX Swiss Exchange. With the tender offer for all publicly held [...]

Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017

09/06/2017 - 17:38

Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that, with today's receipt of [...]

Targovax ASA: Notice of Extraordinary General Meeting

09/06/2017 - 15:41

An Extraordinary General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 30 June 2017 at 09:00 CET. Please find the notice including agenda for the Extraordinary General Meeting and [...]

Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation

09/06/2017 - 14:00

TORONTO, June 09, 2017 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) once again reinforced its role as a global leader in real estate sustainability practices by honouring property managers and [...]

La sixième cérémonie annuelle de remise des prix HOOPP LEAP honore les gestionnaires immobiliers et les locataires pour un rendement, une collaboration et une innovation exceptionnels

09/06/2017 - 14:00

TORONTO, le 9 juin 2017 (GLOBE NEWSWIRE) - Le Healthcare of Ontario Pension Plan (HOOPP) a de nouveau renforcé son rôle de leader mondial dans les pratiques de durabilité immobilière en honorant les gestionnaires [...]

Targovax ASA - Information on the subsequent offering - Key date information

09/06/2017 - 07:52

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Mithra Pharmaceuticals: MITHRA RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY

09/06/2017 - 07:30

PRESS RELEASE Mithra RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY Orphan Drug Designation received from European Medicines Agency for Estetrol (E4) in the treatment of life-threatening [...]